# EDP167 in Healthy Volunteers and Subjects With Mild Dyslipidemia

> **NCT07412080** · PHASE1 · COMPLETED · sponsor: **Eddingpharm (Zhuhai) Co., Ltd.** · enrollment: 40 (actual)

## Conditions studied

- Healthy Adult Male and Female Volunteers
- Mild Dyslipidemia

## Interventions

- **DRUG:** EDP167
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07412080
- **Lead sponsor:** Eddingpharm (Zhuhai) Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-07-01
- **Primary completion:** 2025-12-12
- **Final completion:** 2025-12-12
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2026-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07412080

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07412080, "EDP167 in Healthy Volunteers and Subjects With Mild Dyslipidemia". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT07412080. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*